Amanda Ribas was suspended by the United States Anti-Doping Agency for almost two years, but that sanction has now been reduced.

The USADA announced Friday that Ribas’s two-year suspension for a positive drug test dating back to June 7, 2017, has been terminated, effective immediately. Ribas tested positive for ostarine, an anabolic agent that is prohibited by USADA year-round. However, it has since been determined that the 25-year-old Brazilian’s test failure was the result of a contaminated supplement. She becomes the latest fighter to receive a shortened suspension due to the evidence of contamination, joining a list of fighters that includes Sean O’Malley and Nicco Montano.

Ribas (7-1) signed with the UFC two years ago and was set to debut in July 2017 before her USADA suspension was handed down.

USADA’s statement explains that its decision to terminate Ribas’s suspension stems from “the likelihood that her positive test was the result of an ostarine contaminated dietary supplement product” and that four subsequent tests returned negative results.

Ribas also received a two-year concurrent suspension from the Nevada Athletic Commission. The USADA has informed the NAC of its decision to terminate Ribas’s suspension. Upon resolution of the NAC suspension, Ribas will again be eligible to compete.